Sensus Healthcare, Inc. (NASDAQ:SRTS) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET
Company Participants
Kim Golodetz - Alliance Advisors IR
Joseph Sardano - Chairman and CEO
Michael Sardano - President and General Counsel
Javier Rampolla - CFO
Conference Call Participants
Jason Wittes - ROTH
Anthony Vendetti - Maxim
Ilya Zubkov - Freedom Broker
Jade Montgomery - H.C. Wainwright
Operator
Good afternoon and welcome to the Sensus Healthcare Third Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Kim Golodetz with Alliance Advisors IR. Please go ahead.
Kim Golodetz
Thank you. This is Kim Golodetz with Alliance Advisors IR. Thank you all for participating in today's call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel and Javier Rampolla, Chief Financial Officer.
As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws. All statements other than historical facts that address activities, Sensus Healthcare assumes, plans, expects, believes, intends or anticipates and other similar expressions will, should or may occur in the future, are forward-looking statements. The forward-looking statements are management's beliefs based on currently available information as of the date of this conference call, November 14, 2024.
Sensus Healthcare undertakes no obligation to revise or update any forward-looking statements, except as required by law. All forward-looking statements are subject to risks and uncertainties as described in the company's Forms 10-K and 10-Q.
During today's call, references will be made to certain non-GAAP financial measures. Sensus believes these measures provide useful information for investors, yet they should not be considered as a substitute for GAAP nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in today's financial results press release.
With that said, I'd like to turn the call over to Joe Sardano. Joe?
Joseph Sardano
Thank you, Kim, and good afternoon, everyone. Before we jump into the meat of today's call, let me address the distribution of our earnings news release earlier today. As you know, we typically issue our financial announcements after the markets close. Today we had an accidental disclosure situation with the vendor that handles the distribution of our news releases. So out of an abundance of caution, we issued our third quarter news release and filed our 8-K and 10-Q during live trading hours. We expect to return to our normal timing cadence next quarter.